Format

Send to

Choose Destination
See comment in PubMed Commons below
AJNR Am J Neuroradiol. 2014 Jun;35(6):1157-62. doi: 10.3174/ajnr.A3836. Epub 2014 Mar 27.

Symptom differences and pretreatment asymptomatic interval affect outcomes of stenting for intracranial atherosclerotic disease.

Author information

1
From the Department of Radiology, Santa Clara Valley Medical Center, San Jose, California (M.D.A.).
2
Departments of Neurointerventional Surgery (P.M.M.).
3
Department of Neurology, California Pacific Medical Center, San Francisco, California (J.D.E.).
4
Department of Medicine, St Luke's-Roosevelt Hospital, New York, New York (T.R.S.).
5
Pathology (S.S.), Columbia University, New York, New York.
6
Departments of Neurology (W.S.S.).
7
Radiology and Biomedical Imaging (V.V.H., R.T.H., C.F.D., D.L.C., S.W.H.)Neurological Surgery (V.V.H., R.T.H., C.F.D.), University of California, San Francisco, California.
8
Radiology and Biomedical Imaging (V.V.H., R.T.H., C.F.D., D.L.C., S.W.H.).
9
Radiology and Biomedical Imaging (V.V.H., R.T.H., C.F.D., D.L.C., S.W.H.) matthew.alexander@caa.columbia.edu.

Abstract

BACKGROUND AND PURPOSE:

Different types of symptomatic intracranial stenosis may respond differently to interventional therapy. We investigated symptomatic and pathophysiologic factors that may influence clinical outcomes of patients with intracranial atherosclerotic disease who were treated with stents.

MATERIALS AND METHODS:

A retrospective analysis was performed of patients treated with stents for intracranial atherosclerosis at 4 centers. Patient demographics and comorbidities, lesion features, treatment features, and preprocedural and postprocedural functional status were noted. χ(2) univariate and multivariate logistic regression analysis was performed to assess technical results and clinical outcomes.

RESULTS:

One hundred forty-two lesions in 131 patients were analyzed. Lesions causing hypoperfusion ischemic symptoms were associated with fewer strokes by last contact [χ(2) (1, n = 63) = 5.41, P = .019]. Nonhypoperfusion lesions causing symptoms during the 14 days before treatment had more strokes by last contact [χ(2) (1, n = 136), 4.21, P = .047]. Patients treated with stents designed for intracranial deployment were more likely to have had a stroke by last contact (OR, 4.63; P = .032), and patients treated with percutaneous balloon angioplasty in addition to deployment of a self-expanding stent were less likely to be stroke free at point of last contact (OR, 0.60; P = .034).

CONCLUSIONS:

More favorable outcomes may occur after stent placement for lesions causing hypoperfusion symptoms and when delaying stent placement 7-14 days after most recent symptoms for lesions suspected to cause embolic disease or perforator ischemia. Angioplasty performed in addition to self-expanding stent deployment may lead to worse outcomes, as may use of self-expanding stents rather than balloon-mounted stents.

PMID:
24676000
DOI:
10.3174/ajnr.A3836
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center